Last reviewed · How we verify

NCT04840277: RCT

Remote Hearing Aid Adjustment for Experienced Hearing Aid Users

Completed NA Last updated 3 November 2022
What this trial tests

NA trial testing Remote hearing aid adjustment in Hearing Aids in 92 participants. Completed in 31 May 2022.

Timeline
1 March 2020
Primary endpoint
31 May 2022
31 May 2022

Quick facts

Lead sponsorSodra Alvsborgs Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment92
Start date1 March 2020
Primary completion31 May 2022
Estimated completion31 May 2022
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Sodra Alvsborgs Hospital

Who can join

18 and older, any sex, with Hearing Aids. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many hearing aid users experience substantial communication difficulties that may affect their participation in daily life situations negatively. One of the reasons for experiencing remaining problems could be due to unrealistic expectations, another reason could be that the hearing aid is not well adjusted or that the hearing aid user didn't got sufficient support and follow-up from the audiologist. The purpose of this project is to offer remote hearing aid adjustment as an additional support for experienced hearing aid users.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hearing Aids

Currently open trials in the same condition.

Other Sodra Alvsborgs Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04840277.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing